Skip to main content

datastreet.in

Ajanta Pharma signs pact with Biocon to sell semaglutide in 26 countries

Ajanta Pharma has signed an in-licensing pact with Biocon to market semaglutide across 26 countries in Africa, the Middle East and Central Asia, subject to approvals

Source :- Companies Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *